1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Myneo NV has 1 pending office action. The matter is assigned to 1 examiner, while the profile records 0 distinct art units. That combination places examiner management at the center of prosecution planning without a recorded art-unit distribution.
SKIBINSKY, ANNA is the busiest examiner, with 1 pending matter. Counsel can focus monitoring and response preparation on this single examiner and active record.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SKIBINSKY, ANNA | 1 | 39.1% | +29.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18031139 | Method, System and Computer Program Product for Determining Peptide Immunogenicity | SKIBINSKY, ANNA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18031139 | Method, System and Computer Program Product for Determining Peptide Immunogenicity | SKIBINSKY, ANNA | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18031139 | Method, System and Computer Program Product for Determining Peptide Immunogenicity | SKIBINSKY, ANNA | — | §101§103§112 | Non-Final OA | — | Pending | Apr 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMyneo NV has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Anna Skibinsky has the most, with 1 of Myneo NV's pending office actions.
